163 related articles for article (PubMed ID: 35113358)
1. Lupeol synergizes with doxorubicin to induce anti-proliferative and apoptotic effects on breast cancer cells.
Malekinejad F; Kheradmand F; Khadem-Ansari MH; Malekinejad H
Daru; 2022 Jun; 30(1):103-115. PubMed ID: 35113358
[TBL] [Abstract][Full Text] [Related]
2. Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro.
Abrahams B; Gerber A; Hiss DC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474312
[TBL] [Abstract][Full Text] [Related]
3. [Effect of lupeol on migration and invasion of human breast cancer MDA-MB-231 cells and its mechanism].
Wang M; Cui HX; Sun C; Li G; Wang HL; Xia CH; Wang YC; Liu JC
Yao Xue Xue Bao; 2016 Apr; 51(4):558-62. PubMed ID: 29859524
[TBL] [Abstract][Full Text] [Related]
4. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects.
Li J; Wu Y; Wang D; Zou L; Fu C; Zhang J; Leung GP
Pharmacol Res; 2019 Aug; 146():104313. PubMed ID: 31202781
[TBL] [Abstract][Full Text] [Related]
5. Potential targeting of Hep3B liver cancer cells by lupeol isolated from Avicennia marina.
Eldohaji LM; Fayed B; Hamoda AM; Ershaid M; Abdin S; Alhamidi TB; Mohammad MG; Omar HA; Soliman SSM
Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100120. PubMed ID: 34085721
[TBL] [Abstract][Full Text] [Related]
6. In vitro synergistic effect of hesperidin and doxorubicin downregulates epithelial-mesenchymal transition in highly metastatic breast cancer cells.
Amalina ND; Salsabila IA; Zulfin UM; Jenie RI; Meiyanto E
J Egypt Natl Canc Inst; 2023 Mar; 35(1):6. PubMed ID: 36967442
[TBL] [Abstract][Full Text] [Related]
7. Anti-Cancer Effects of Epigenetics Drugs Scriptaid and Zebularine in Human Breast Adenocarcinoma Cells.
Yap ZH; Kong WY; Azeez AR; Fang CM; Ngai SC
Anticancer Agents Med Chem; 2022; 22(8):1582-1591. PubMed ID: 34102995
[TBL] [Abstract][Full Text] [Related]
8. The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells.
Czeczuga-Semeniuk E; Wołczyński S; Dabrowska M; Dziecioł J; Anchim T
Folia Histochem Cytobiol; 2004; 42(4):221-7. PubMed ID: 15704648
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma.
Chaudhary S; Chandrashekar KS; Pai KS; Setty MM; Devkar RA; Reddy ND; Shoja MH
BMC Complement Altern Med; 2015 Mar; 15():50. PubMed ID: 25886964
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic Acid Incorporation Is Not Affected by Doxorubicin Chemotherapy in either Whole Cell or Lipid Raft Phospholipids of Breast Cancer Cells in vitro and Tumor Phospholipids in vivo.
Newell M; Patel D; Goruk S; Field CJ
Lipids; 2020 Sep; 55(5):549-565. PubMed ID: 32588470
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells.
Alsherbiny MA; Bhuyan DJ; Radwan I; Chang D; Li CG
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360606
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of ring-A modified lupeol derivatives and their anti-proliferative activity: identification of potent lead active against MCF-7 breast cancer cells.
Narendar K; Mandha Chander P; Abhisheik Eedara C; Andugulapati SB; Ramalingam V; SureshBabu K; Vijayachari P
Nat Prod Res; 2024; 38(2):304-310. PubMed ID: 36083601
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of in vitro anticancer activity of Ocimum basilicum, Alhagi maurorum, Calendula officinalis and their parasite Cuscuta campestris.
Behbahani M
PLoS One; 2014; 9(12):e116049. PubMed ID: 25548920
[TBL] [Abstract][Full Text] [Related]
14. Apatinib increases anticancer potential of doxorubicin in breast cancer cells.
Aghaei E; Soltanzadeh H; Kohan L; Heiat M
Mol Biol Rep; 2023 Dec; 50(12):10137-10145. PubMed ID: 37921980
[TBL] [Abstract][Full Text] [Related]
15. Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways.
Wei T; Xiaojun X; Peilong C
Biomed Pharmacother; 2020 Jan; 121():109139. PubMed ID: 31707337
[TBL] [Abstract][Full Text] [Related]
16. Synergic Effects of Doxorubicin and Melatonin on Apoptosis and Mitochondrial Oxidative Stress in MCF-7 Breast Cancer Cells: Involvement of TRPV1 Channels.
Koşar PA; Nazıroğlu M; Övey İS; Çiğ B
J Membr Biol; 2016 Apr; 249(1-2):129-40. PubMed ID: 26525975
[TBL] [Abstract][Full Text] [Related]
17. Platycodin D from Platycodonis Radix enhances the anti-proliferative effects of doxorubicin on breast cancer MCF-7 and MDA-MB-231 cells.
Tang ZH; Li T; Gao HW; Sun W; Chen XP; Wang YT; Lu JJ
Chin Med; 2014; 9():16. PubMed ID: 24982689
[TBL] [Abstract][Full Text] [Related]
18. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
Chen JM; Bai JY; Yang KX
IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
[TBL] [Abstract][Full Text] [Related]
19. Regulation of signaling pathways involved in lupeol induced inhibition of proliferation and induction of apoptosis in human prostate cancer cells.
Prasad S; Nigam N; Kalra N; Shukla Y
Mol Carcinog; 2008 Dec; 47(12):916-24. PubMed ID: 18404669
[TBL] [Abstract][Full Text] [Related]
20. Lupeol induces S-phase arrest and mitochondria-mediated apoptosis in cervical cancer cells.
Prasad N; Sabarwal A; Yadav UCS; Singh RP
J Biosci; 2018 Jun; 43(2):249-261. PubMed ID: 29872014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
